Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders

Clinical trial NCT00636909 · COMPLETED

Trial details

NCT number: NCT00636909
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

AML ALL CML Chronic Phase, Accelerated Phase, or Blast Crisis CLL MDS RELAPSED NON-HODGKIN'S OR HODGKIN'S LYMPHOMA APLASTIC ANEMIA MULTIPLE MYELOMA MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET)

Start date: 1999-07-01
Primary completion: 2006-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.